Skip to main content
. Author manuscript; available in PMC: 2009 Jun 2.
Published in final edited form as: Neurochem Int. 2008 Dec 9;54(3-4):172–179. doi: 10.1016/j.neuint.2008.08.013

Fig. 5.

Fig. 5

Suppressed expression of Nrf2 in the tub/tub mice and the SF-protective effect. (A and B) Gene expression measured with RT-PCR at P30; (C and D) protein level measurements by Western blot at P60 and P90. For gene expression measurements, 18S rRNA was used as the internal control. For protein assay, CBB was used as the control. SF treatment: daily intraperitoneally injection with SF (50 mg/kg in PBS) or PBS alone for 20 days from P10. The measurements are expressed as mean ± S.D. (n = 4 in each group). *p < 0.05; **p < 0.01.